文献速递慢阻肺肺栓塞与肺血管病

弥散功能不成比例受损可预测慢阻肺患者肺动脉高压伴肺血管阻力升高

Disproportionate impairment in diffusing capacity predicts pulmonary hypertension with an elevated pulmonary vascular resistance in COPD.
PubMed 文献 · Thorax · 2026-05-14

本研究纳入两所学术医疗中心接受右心导管检查的411例慢阻肺患者,约40%存在肺动脉高压伴肺血管阻力升高。FEV1/DLCO比值每增加0.1,该类肺动脉高压发生率增加12-14%;比值>1.4时预测特异性达75%,联合超声三尖瓣反流速度可提升判别效能。

要点

  • FEV1/DLCO比值>1.4对慢阻肺患者肺动脉高压伴肺血管阻力升高具有良好特异性(75%)。
  • FEV1/DLCO比值每增加0.1,肺动脉高压伴肺血管阻力升高发生率增加12-14%。
  • FEV1/DLCO联合超声三尖瓣反流速度可增强对肺动脉高压伴肺血管阻力升高的判别能力。

核心结论

  • 弥散功能不成比例下降可预测慢阻肺患者肺动脉高压伴肺血管阻力升高。
  • FEV1/DLCO比值应考虑用于慢阻肺患者肺动脉高压的评估。

研究设计与样本

  • 纳入两所学术医疗中心接受右心导管检查的慢阻肺患者,共411例。
  • 采用调整多分类模型检验FEV1/DLCO与血流动力学模式的关联,并生成受试者工作特征曲线评估判别效能。

主要发现

  • 411例中约40%存在肺动脉高压伴肺血管阻力升高。
  • FEV1/DLCO比值每增加0.1,肺动脉高压伴肺血管阻力升高发生率较无肺动脉高压增加12-14%。
  • FEV1/DLCO比值判别效能中等(C统计量0.68-0.72),联合超声三尖瓣反流速度升高后提升至0.78-0.82。
  • FEV1/DLCO比值>1.4时预测肺动脉高压伴肺血管阻力升高的特异性为75%。

关键数值与推荐

  • FEV1/DLCO比值>1.4作为预测肺动脉高压伴肺血管阻力升高的特异性阈值(特异性75%)。
  • FEV1/DLCO比值每增加0.1对应肺动脉高压伴肺血管阻力升高发生率增加12-14%。
  • FEV1/DLCO单独C统计量0.68-0.72,联合超声三尖瓣反流速度升高后C统计量0.78-0.82。

临床怎么用

  • 在慢阻肺患者评估中可考虑计算FEV1/DLCO比值以提示肺动脉高压伴肺血管阻力升高的可能。
  • FEV1/DLCO比值>1.4提示需进一步评估肺动脉高压,可结合超声三尖瓣反流速度提高判别效能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current guidelines for the evaluation of chronic obstructive pulmonary disease (COPD) do not recommend screening for pulmonary hypertension (PH), despite the high prevalence and impact on outcomes. A simple screening tool to identify patients with an elevated pulmonary vascular resistance (PVR) is urgently needed, as they may benefit from PH-specific therapy and more urgent referral for lung transplantation. RESEARCH QUESTION: We sought to examine whether a ratio of forced expiratory volume in 1 s (FEV1) to diffusing capacity (DLCO) predicts haemodynamic patterns in COPD. STUDY DESIGN AND METHODS: Individuals with COPD who underwent right heart catheterisation from two academic medical centres were included. Adjusted multinomial models tested associations between FEV1/DLCO and haemodynamic patterns. Receiver operating curves were generated to assess the discriminative performance of the FEV1/DLCO ratio in predicting PH with an elevated PVR. RESULTS: Approximately 40% of the 411 individuals included had PH with an elevated PVR. For every 0.1 increase in the FEV1/DLCO ratio, there was a 12-14% increased rate of PH with an elevated PVR compared with No PH. FEV1/DLCO ratio had moderate discriminative performance (C-statistic 0.68-0.72), which was strengthened when combined in a model with elevated tricuspid regurgitant jet velocity on echocardiography (C-statistic 0.78-0.82). Above a threshold of 1.4, FEV1/DLCO demonstrated good specificity (75%) in predicting PH with an elevated PVR. INTERPRETATION: These findings suggest that disproportionate reductions in DLCO predict PH with an elevated PVR in a COPD population. The FEV1/DLCO ratio should be considered in the evaluation of PH in COPD.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Balasubramanian A, Hemnes AR, Brittain EL, et al. Disproportionate impairment in diffusing capacity predicts pulmonary hypertension with an elevated pulmonary vascular resistance in COPD. Thorax. 2026. PMID: 41309285. doi:10.1136/thorax-2025-223921

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。